In focus · trending topic

Colorectal Cancer

18 stories · following the connections

eFFECTOR Publishes the Design and Profile of eFT508 in Peer Reviewed Journal of Medicinal Chemistry

By Nasdaq OMXApr 26, 2018, 11:31 AM UTC

eFFECTOR Presents Data on the Discovery and Structure of eFT226, a Novel Inhibitor of eIF4A, at the AACR 2018 Annual Meeting

By Nasdaq OMXApr 16, 2018, 12:01 PM UTC

Treos Bio Announces Activation of U.S. Clinical Trial Site for Phase 1 Study of PolyPEPI™ Precision Cancer Vaccine for Patients with Metastatic Colorectal Cancer

By Nasdaq OMXApr 11, 2018, 12:15 PM UTC

eFFECTOR Announces Appointment of John W. Smither to its Board of Directors

By Nasdaq OMXMar 23, 2018, 6:00 PM UTC

March 22 is National Lynch Syndrome Day

By Nasdaq OMXMar 22, 2018, 9:41 PM UTC

Clinical Data for eFFECTOR Therapeutics’ Lead Candidate eFT508 Demonstrates Clinical Activity, Well-Tolerated Safety Profile

By Nasdaq OMXDec 11, 2017, 3:00 PM UTC

Expanding colorectal cancer patient support

By Nasdaq OMXDec 5, 2017, 1:20 PM UTC

Reaching Young People with the Realities of Colorectal Cancer

By Nasdaq OMXNov 21, 2017, 2:12 PM UTC